• The Role of Vitamin D Deficiency Prevention in Improving Obstetric, Perinatal and Long)Term Outcomes
en To content Full text of article

The Role of Vitamin D Deficiency Prevention in Improving Obstetric, Perinatal and Long)Term Outcomes

Ukrainian Journal of Perinatology and Pediatrics. 2020. 4(84): 35-40; doi 10.15574/PP.2020.84.35
Davydova Iu. V., Lymanska A. Iu., Neroznak Yu. P.
SI "Institute of Pediatrics, Obstetrics and Gynecology name after academic O.M. Lukyanova NAMS of Ukraine", Kyiv

For citation: Davydova IuV, Lymanska AIu, Neroznak YuP. (2020). The role of vitamin D deficiency prevention in improving obstetric, perinatal and longterm outcomes. Ukrainian Journal of Perinatology and Pediatrics. 4(84): 3540. doi 10.15574/PP.2020.84.35
Article received: Aug 21, 2020. Accepted for publication: Dec 12, 2020.

Much attention is paid to deficiencies prevention during pregnancy, since they negatively affect not only metabolic processes, including fetoplacental complex, but also the condition of the fetus, the newborn, and physical and mental development of the child in the future. Summarizing the recommendations for the use of vitamin D during pregnancy, it should be noted that the typical prophylactic dose is 400 IU/day starting from the first trimester. However, we should consider the use of corrective doses in the second and third trimesters when the fetal skeleton is growing and developing. A high dose of vitamin D (2000 IU/day) is recommended for women at high risk of developing hypertensive complications of pregnancy (a history of preeclampsia, in particular, arising before 28 weeks, arterial hypertension, chronic kidney disease), as well as pregnant women with comorbidity (systemic red lupus, rheumatoid arthritis, multiple sclerosis, cardiovascular disease, inflammatory bowel disease, oncological pathology). For women at risk of vitamin D deficiency, the recommended dose is less than 1000 IU/day. In case of confirmed vitamin D deficiency (<25-30 nmol/L), a correction dose of 2000-4000 IU/day is prescribed for 11 weeks to provide a cumulative dose of about 150,000 or 300,000 units in the second or third trimesters. Today, a sufficient number of vitamin D preparations are presented on the pharmaceutical market of Ukraine, among which one should pay attention to "Olidetrim" (Polpharma, Poland) in the form of oil solution in capsules ensuring its absorption and assimilation. Depending on the dosage, each capsule of the preparation contains 2000 IU or 4000 IU of vitamin D3 (cholecalciferol). In addition to the fat-soluble form, vitamin D preparation Aquadetrim® (Polpharma, Poland) is registered and successfully used in Ukraine. This is a unique form of vitamin D3 based on nanomycellae, which provides better absorption of vitamin D in the intestine.
Key words: vitamin D, deficiency, pregnancy, fetus, prevention.

REFERENСES

1. American College of Obstetricians and Gynaecologists. (2011). Committee opinion. Committee on Obstetric Practice. Vitamin D: Screening and supplementation during pregnancy. Obstetrics&Gynecology. 118 (1): 197-198. https://doi.org/10.1097/AOG.0b013e318227f06b; PMid:21691184

2. Barrera D, Noyola-Martinez N, Avila E, Halhali A, Larrea F, Diaz L. (2012). Calcitriol inhibits interleukin-10 expression in cultured human trophoblasts under normal and inflammatory conditions. Cytokine. 57 (3): 316-321. https://doi.org/10.1016/j.cyto.2011.11.020; PMid:22182686

3. Bikle DD, Gee E, Halloran B, Haddad JG. (1984). Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 74 (6): 1966-1971. https://doi.org/10.1172/JCI111617; PMid:6549014 PMCid:PMC425383

4. Brustad N, Garland J, Thorsen J, Sevelsted A et al. (2020). Effect of High-Dose vs Standard-Dose Vitamin D Supplementation in Pregnancy on Bone Mineralization in Offspring Until Age 6 Years A Prespecified Secondary Analysis of a Double-Blinded, Randomized Clinical Trial. JAMA Pediatr. 174 (5): 419-427. https://doi.org/10.1001/jamapediatrics.2019.6083; PMid:32091548

5. Cleal JK, Day PE, Simner CL et al. (2015). Placental amino acid transport may be regulated by maternal vitamin D and vitamin D-binding protein: results from the Southampton Women's Survey. Br J Nutr. 113: 1903-1910. https://doi.org/10.1017/S0007114515001178; PMid:25940599 PMCid:PMC4498463

6. Cooper C, Harvey NC, Bishop NJ et al. (2016). Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlledtrial. Lancet. 4 (5): 393-402.

7. Dror DK, Allen LH. (2010). Vitamin D inadequacy in pregnancy: biology, outcomes, and interventions. Nutrition Reviews. 68: 465-477. https://doi.org/10.1111/j.1753-4887.2010.00306.x; PMid:20646224

8. Harvey NC, Holroyd C, Ntani G et al. (2014). Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 18: 45. https://doi.org/10.3310/hta18450; PMCid:PMC4124722

9. Harvey NC, Moon RJ, Sayer AA et al. (2013). Southampton Women's Survey Study Group. Maternal antenatal vitamin D status and offspring muscle development: findings from the Southampton Women's Survey. J Clin Endocrinol Metab. 99: 330-337. https://doi.org/10.1210/jc.2013-3241; PMid:24178796 PMCid:PMC3880861

10. Holick MF. (2004). Vitamin D: importance in the prevention of cancers, Type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 79: 362-371. https://doi.org/10.1093/ajcn/79.3.362; PMid:14985208

11. Holick MF. (2007). Vitamin D deficiency. New England Journal of Medicine. 357: 266-281. https://doi.org/10.1056/NEJMra070553; PMid:17634462

12. Holick MF. (2009). Vitamin D status: measurement, interpretation, and clinical application. Annals of Epidemiology. 19: 73-78. https://doi.org/10.1016/j.annepidem.2007.12.001; PMid:18329892 PMCid:PMC2665033

13. Javaid MK, Crozier SR, Harvey NC et al. (2006). Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet. 367: 36-43. https://doi.org/10.1016/S0140-6736(06)67922-1

14. Motamed S, Nikooyeh B, Kashanian M et al. (2020). Evaluation of the efficacy of two doses of vitamin D supplementation on glycemic, lipidemic and oxidative stress biomarkers during pregnancy: a randomized clinical trial. BMC Pregnancy Childbirth. 20: 619. https://doi.org/10.1186/s12884-020-03311-1; PMid:33054794 PMCid:PMC7556979

15. Ross C, Taylor CL, Yaktine AL, Del Valle HB. (2011). Institute of Medicine (US) Committee. Dietary reference intakes for calcium and vitamin D. Washington DC: National Academy Press. https://doi.org/10.17226/13050

16. SACN. (2016). Vitamin D and Health. Scientific Advisory Committee on Nutrition (SACN).

17. Thorne-Lyman A, Fawzi WW. (2012). Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatric and Perinatal Epidemiology. 26 (1): 75-90. https://doi.org/10.1111/j.1365-3016.2012.01283.x; PMid:22742603 PMCid:PMC3843348

18. Wagner CL, Greer FR. (2008). Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. American Academy of Pediatrics Section on Breastfeeding, American Academy of Pediatrics Committee on Nutrition. Pediatrics. 122: 1142-1152. https://doi.org/10.1542/peds.2008-1862; PMid:18977996

19. Wagner CL, Hollis BW, Kotsa K. (2017). Vitamin D administration during pregnancy as prevention for pregnancy, neonatal and postnatal complications. Reviews in Endocrine Metabolism Disorders. 18: 307-322. https://doi.org/10.1007/s11154-017-9414-3; PMid:28214921

20. Wei SQ et al. (2012). Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG: International Journal of Obstetrics and Gynaecology. 119: 832-839. https://doi.org/10.1111/j.1471-0528.2012.03307.x; PMid:22462640

21. Wei SQ, Audibert F, Hidiroglou N, Sarafin K, Julien P, Wu Y, Luo ZC, Fraser WD. (2012). Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG. 119 (7): 832-839. https://doi.org/10.1111/j.1471-0528.2012.03307.x; PMid:22462640

22. Wei S-Q, Qi H-P, Luo Z-C et al. (2013). Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis. The Journal of Maternal-fetal&neonatal medicine. 26 (9): 889-899. https://doi.org/10.3109/14767058.2013.765849; PMid:23311886

23. Xu L, Lee M, Jeyabalan A, Roberts JM. (2014). The relationship of hypovitaminosis D and IL-6 in preeclampsia. Am J Obstet Gynecol. 210 (2):149. https://doi.org/10.1016/j.ajog.2013.09.037; PMid:24080305 PMCid:PMC4040267